Complement 5a Receptor Antagonist [EPC]

6762 reported adverse events

Drugs of this class: AVACOPAN

These side effects are most commonly reported by patients taking drugs of the Complement 5a Receptor Antagonist [EPC] class:

# Side effect Count
0 HOSPITALISATION 1026
1 DEATH 414
2 OFF LABEL USE 373
3 THERAPY INTERRUPTED 354
4 DIARRHOEA 272
5 FATIGUE 270
6 NAUSEA 249
7 PNEUMONIA 245
8 HEADACHE 183
9 COVID-19 176
See all common reactions for Complement 5a Receptor Antagonist [EPC]

Drugs of the Complement 5a Receptor Antagonist [EPC] class are most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 SPINAL ARTERY THROMBOSIS 3 0.1111
1 CHRONIC ACTIVE EPSTEIN-BARR VIRUS INFECTION 5 0.1111
2 RAOULTELLA ORNITHINOLYTICA INFECTION 8 0.1039
3 SUBGLOTTIC LARYNGITIS 2 0.0800
4 ANTINEUTROPHIL CYTOPLASMIC ANTIBODY INCREASED 13 0.0774
5 SUSPECTED DRUG-INDUCED LIVER INJURY 15 0.0750
6 ABDOMINAL WALL PAIN 1 0.0588
7 VANISHING BILE DUCT SYNDROME 60 0.0538
8 INTERFERON GAMMA RELEASE ASSAY POSITIVE 6 0.0366
9 GRANULOMATOSIS WITH POLYANGIITIS 43 0.0356
See all enriched reactions for Complement 5a Receptor Antagonist [EPC]